• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.

作者信息

Ernst Matthew S, Heng Daniel Y C

机构信息

Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.

Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.

出版信息

Eur Urol. 2023 Jul;84(1):e18-e19. doi: 10.1016/j.eururo.2023.03.032. Epub 2023 Apr 18.

DOI:10.1016/j.eururo.2023.03.032
PMID:37080894
Abstract
摘要

相似文献

1
Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.回复赵炳浩、邢浩和马文斌致编辑的信，内容涉及：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》。2023年；84卷：109 - 116页。
Eur Urol. 2023 Jul;84(1):e18-e19. doi: 10.1016/j.eururo.2023.03.032. Epub 2023 Apr 18.
2
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.回复：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》。2023年；84卷：109 - 116页。
Eur Urol. 2023 Jul;84(1):e16-e17. doi: 10.1016/j.eururo.2023.02.030. Epub 2023 Apr 13.
3
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.回复：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》。2023年；84卷：109 - 116页。
Eur Urol. 2023 Oct;84(4):e96-e97. doi: 10.1016/j.eururo.2023.05.041. Epub 2023 Jun 28.
4
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol 2023;84:109-16.回复：马修·S·恩斯特、维沙尔·纳瓦尼、J·康纳·韦尔斯等人。国际转移性肾细胞癌数据库联盟预后分组在当代转移性肾细胞癌一线联合治疗中的结果。《欧洲泌尿外科杂志》2023年；84卷：109 - 16页。
Eur Urol. 2023 Dec;84(6):e143-e144. doi: 10.1016/j.eururo.2023.08.015. Epub 2023 Sep 1.
5
Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002.回复： Kosuke Takemura、Matthew S. Ernst、Vishal Navani等人。联合免疫治疗时代接受延迟、 upfront或不进行减瘤性肾切除术的转移性肾细胞癌患者的特征：国际转移性肾细胞癌数据库联盟的结果。《欧洲泌尿外科肿瘤学》。即将发表。https://doi.org/10.1016/j.euo.2023.10.002 。
Eur Urol Oncol. 2024 Jun;7(3):642-643. doi: 10.1016/j.euo.2023.12.011. Epub 2024 Jan 17.
6
Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8.致罗伯托·亚科韦利、沃尔特·阿尔蒂巴尼和詹保罗·托尔托拉给编辑的信的回复，主题为：伊恩·D·戴维斯、谢婉玲、卡梅尔·佩扎罗等人。根据国际转移性肾细胞癌数据库联盟预后分类中与基线的变化评估二线靶向治疗对肾细胞癌的疗效。《欧洲泌尿外科杂志》2017年；71卷：970 - 978页
Eur Urol. 2017 Jun;71(6):e177-e178. doi: 10.1016/j.eururo.2016.12.013. Epub 2016 Dec 29.
7
Reply to Yudai Ishiyama and Fumihiko Urabe's Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006.
Eur Urol. 2024 Dec;86(6):e143-e144. doi: 10.1016/j.eururo.2024.03.016. Epub 2024 Mar 25.
8
Re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. 2024;86:488-492.回复：武村浩介、奥德丽·勒梅林、马修·S·恩斯特等。肾细胞癌脑转移患者一线治疗的结局：国际转移性肾细胞癌数据库联盟的结果。《欧洲泌尿外科杂志》。2024年；86：488 - 492。
Eur Urol. 2024 Dec;86(6):e142. doi: 10.1016/j.eururo.2024.02.028. Epub 2024 Apr 10.
9
Re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8: The Change in Baseline IMDC Prognostic Category: From the Past, Implications for the Future.回复：伊恩·D·戴维斯、谢婉玲、卡梅尔·佩扎罗等。根据国际转移性肾细胞癌数据库联盟预后分类的基线变化评估二线靶向治疗对肾细胞癌的疗效。《欧洲泌尿外科杂志》2017年；71卷：970 - 978页：基线国际转移性肾细胞癌数据库联盟预后分类的变化：从过去到未来的启示
Eur Urol. 2017 Jun;71(6):e175-e176. doi: 10.1016/j.eururo.2016.12.012. Epub 2016 Dec 30.
10
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?回复：比马尔·宾迪、杰弗里·格雷厄姆、J·康纳·韦尔斯等人。初诊转移性肾细胞癌患者的延期减瘤性肾切除术。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.04.038：减瘤性肾切除术：适用于谁以及何时进行？
Eur Urol Oncol. 2020 Aug;3(4):559-560. doi: 10.1016/j.euo.2020.05.011. Epub 2020 Jun 15.